Ma, J., Li, J., Yao, X., Lin, S., Gu, Y., Xu, J., . . . Zhang, H. (2017). FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide. Oncol Rep.

Ma, Jian, Jianlei Li, Xiaoling Yao, Shuangjun Lin, Ye Gu, Jianfang Xu, Zixin Deng, Wei Ma, and Haiping Zhang. "FIGNL1 Is Overexpressed in Small Cell Lung Cancer Patients and Enhances NCI-H446 Cell Resistance to Cisplatin and Etoposide." Oncol Rep 2017.

Ma, Jian, et al. "FIGNL1 Is Overexpressed in Small Cell Lung Cancer Patients and Enhances NCI-H446 Cell Resistance to Cisplatin and Etoposide." Oncol Rep 2017.